Zobrazeno 1 - 10
of 220
pro vyhledávání: '"J. Tessitore"'
Autor:
Berry, Laurel K.1 (AUTHOR), Pullikuth, Ashok K.2 (AUTHOR), Stearns, Kristen L.1 (AUTHOR), Wang, Yuezhu2 (AUTHOR), Wagner, Calvin J.2 (AUTHOR), Chou, Jeff W.3 (AUTHOR), Darby, Janelle P.1 (AUTHOR), Kelly, Michael G.1 (AUTHOR), Mall, Raghvendra4,5 (AUTHOR), Leung, Ming3 (AUTHOR), Chifman, Julia6 (AUTHOR), Miller, Lance D.2,3 (AUTHOR) ldmiller@wakehealth.edu
Publikováno v:
Journal of Translational Medicine. 11/20/2024, Vol. 22, p1-21. 21p.
Autor:
Pușcașu, Ciprian1 (AUTHOR) ciprian.puscasu@umfcd.ro, Chiriță, Cornel1 (AUTHOR) cornel.chirita@umfcd.ro, Negreș, Simona1 (AUTHOR), Blebea, Nicoleta Mirela2 (AUTHOR) nicoleta.blebea@gmail.com
Publikováno v:
International Journal of Molecular Sciences. Oct2024, Vol. 25 Issue 20, p11111. 35p.
Autor:
Bruna-Mejias, Alejandro1 (AUTHOR) alejandro.bruna@upla.cl, Baeza, Vicente2 (AUTHOR) vicentebaeza2000@gmail.com, Gamboa, Javiera2 (AUTHOR) javigamboaa@gmail.com, Baez Flores, Belen2 (AUTHOR) belenbaezflores@gmail.com, San Martin, Jessica2 (AUTHOR) jessicasanmartinp@gmail.com, Astorga, Constanza3 (AUTHOR) constanzaastorga21@gmail.com, Leyton, Javiera2 (AUTHOR) javiera.leyton.si@gmail.com, Nova-Baeza, Pablo2 (AUTHOR) pablo.nova@usach.cl, Orellana-Donoso, Mathias3,4 (AUTHOR) mathor94@gmail.com, Suazo-Santibañez, Alejandra5 (AUTHOR) alej.suazo@gmail.com, Becerra-Farfán, Alvaro6 (AUTHOR) alvaro.becerra@ubo.cl, Oyanedel-Amaro, Gustavo7 (AUTHOR) g.oyanedelamaro@gmail.com, Valenzuela-Fuenzalida, Juan Jose2 (AUTHOR) juan.kine.2015@gmail.com
Publikováno v:
Pharmaceuticals (14248247). Sep2024, Vol. 17 Issue 9, p1165. 15p.
Autor:
B. Fallon, Harriet A. Bering, J. Tessitore, Jerome E. Groopman, Mark S. Huberman, D. Levitt, Paul S, H. Sonnenborn, J. Zeffren
Publikováno v:
Cancer. 68:1708-1713
This study was undertaken to define the maximum tolerated dose (MTD) of recombinant interleukin-2 (IL-2) that could be combined with a fixed dose of alpha-2a-interferon (alpha-IFN) in an outpatient setting. The schedule called for IL-2 to be given by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c21d495a570dd25f32ef906cad5abb7c
https://doi.org/10.1002/1097-0142(19911015)68:8<1708::aid-cncr2820680810>3.0.co
https://doi.org/10.1002/1097-0142(19911015)68:8<1708::aid-cncr2820680810>3.0.co
Autor:
Zalmen A. Arlin, Tauseef Ahmed, A. Skelos, P. Arnold, B. Fallon, Abraham Mittelman, D. Levitt, C. Puccio, J. Zeffren, M. Wick, J. Tessitore, S. Savona, Robert C. Eyre, Jerome E. Groopman, Gafney E, Mark S. Huberman
Publikováno v:
Cancer. 66:664-669
Preclinical data suggest synergy of interleukin-2 (IL-2) combined with alpha-interferon (IFN). In addition, toxicities of IL-2 may be decreased by intermittent continuous infusion. The purpose of this trial was to determine the maximum tolerated dose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::84adb2648558ab68a1b1a4f568b5039e
https://doi.org/10.1002/1097-0142(19900815)66:4<664::aid-cncr2820660411>3.0.co
https://doi.org/10.1002/1097-0142(19900815)66:4<664::aid-cncr2820660411>3.0.co
Publikováno v:
2006 Conference on Lasers and Electro-Optics and 2006 Quantum Electronics and Laser Science Conference.
Life-test for high reliability laser pumps demands highly stable current sources. Telops has engineered a novel current source that meets stabilities of 200 ppm/1000 hr. This paper presents the design and assessment of performance.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::340f5290413edc4722ded3d0a0c8058c
https://doi.org/10.1109/cleo.2006.4628848
https://doi.org/10.1109/cleo.2006.4628848
Autor:
M, Huberman, H, Bering, B, Fallon, J, Tessitore, H, Sonnenborn, S, Paul, J, Zeffren, D, Levitt, J, Groopman
Publikováno v:
Cancer. 68(8)
This study was undertaken to define the maximum tolerated dose (MTD) of recombinant interleukin-2 (IL-2) that could be combined with a fixed dose of alpha-2a-interferon (alpha-IFN) in an outpatient setting. The schedule called for IL-2 to be given by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::728832376dce3de33450e81447e68a66
https://pubmed.ncbi.nlm.nih.gov/1913512
https://pubmed.ncbi.nlm.nih.gov/1913512
Autor:
A, Mittelman, M, Huberman, C, Puccio, B, Fallon, J, Tessitore, S, Savona, R, Eyre, E, Gafney, M, Wick, A, Skelos
Publikováno v:
Cancer. 66(4)
Preclinical data suggest synergy of interleukin-2 (IL-2) combined with alpha-interferon (IFN). In addition, toxicities of IL-2 may be decreased by intermittent continuous infusion. The purpose of this trial was to determine the maximum tolerated dose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::19dee9143493f9af738c1631e8441503
https://pubmed.ncbi.nlm.nih.gov/2386896
https://pubmed.ncbi.nlm.nih.gov/2386896
Autor:
Tornøe, Anders Schou1 (AUTHOR), Pind, Alison Holten1 (AUTHOR), Laursen, Christina Cleveland Westerdahl1 (AUTHOR), Andersen, Cheme1 (AUTHOR), Maagaard, Mathias1 (AUTHOR) mathias.maagaard@gmail.com, Mathiesen, Ole1,2 (AUTHOR)
Publikováno v:
Acta Anaesthesiologica Scandinavica. Nov2023, Vol. 67 Issue 10, p1306-1321. 16p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.